| Brain-derived neurotrophic factor, stress and depression: a minireview B Yuluğ, E Ozan, AS Gönül, E Kilic Brain research bulletin 78 (6), 267-269, 2009 | 138 | 2009 |
| Particular phosphorylation of PI3K/Akt on Thr308 via PDK-1 and PTEN mediates melatonin's neuroprotective activity after focal cerebral ischemia in mice U Kilic, AB Caglayan, MC Beker, MY Gunal, B Caglayan, E Yalcin, ... Redox biology 12, 657-665, 2017 | 131 | 2017 |
| Childhood and juvenile onset multiple sclerosis: clinical and paraclinical features S Ozakbas, E Idiman, B Baklan, B Yulug Brain and Development 25 (4), 233-236, 2003 | 111 | 2003 |
| Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase‐3 and is suitable as an add‐on treatment to tissue‐plasminogen activator E Kilic, Ü Kilic, B Yulug, DM Hermann, RJ Reiter Journal of pineal research 36 (3), 171-176, 2004 | 103 | 2004 |
| The therapeutic role of minocycline in Parkinson’s disease S Cankaya, B Cankaya, U Kilic, E Kilic, B Yulug Drugs in context 8, 2019 | 87 | 2019 |
| Acute and post-acute neuromodulation induces stroke recovery by promoting survival signaling, neurogenesis, and pyramidal tract plasticity AB Caglayan, MC Beker, B Caglayan, E Yalcin, A Caglayan, B Yulug, ... Frontiers in cellular neuroscience 13, 144, 2019 | 86 | 2019 |
| Therapeutic role of rifampicin in Alzheimer's disease B Yulug, L Hanoglu, M Ozansoy, D Isık, U Kilic, E Kilic, WR Schabitz Psychiatry and clinical neurosciences 72 (3), 152-159, 2018 | 80 | 2018 |
| Effects of normobaric oxygen and melatonin on reperfusion injury: role of cerebral microcirculation MC Beker, AB Caglayan, T Kelestemur, B Caglayan, E Yalcin, B Yulug, ... Oncotarget 6 (31), 30604, 2015 | 77 | 2015 |
| Does sleep disturbance affect the amyloid clearance mechanisms in A lzheimer's disease? B Yulug, L Hanoglu, E Kilic Psychiatry and clinical neurosciences 71 (10), 673-677, 2017 | 58 | 2017 |
| Allyl isothiocyanate attenuates oxidative stress and inflammation by modulating Nrf2/HO-1 and NF-κB pathways in traumatic brain injury in mice B Caglayan, E Kilic, A Dalay, S Altunay, M Tuzcu, F Erten, C Orhan, ... Molecular biology reports 46, 241-250, 2019 | 57 | 2019 |
| RIFAMPICIN: An antibiotic with brain protective function B Yulug, L Hanoglu, E Kilic, WR Schabitz Brain research bulletin 107, 37-42, 2014 | 57 | 2014 |
| Comprehensive research on past and future therapeutic strategies devoted to treatment of amyotrophic lateral sclerosis B Sever, H Ciftci, H DeMirci, H Sever, F Ocak, B Yulug, H Tateishi, ... International journal of molecular sciences 23 (5), 2400, 2022 | 56 | 2022 |
| Rifampicin attenuates brain damage in focal ischemia B Yulug, Ü Kilic, E Kilic, M Bähr Brain research 996 (1), 76-80, 2004 | 50 | 2004 |
| Left lateral parietal rTMS improves cognition and modulates resting brain connectivity in patients with Alzheimer’s disease: Possible role of BDNF and oxidative stress HA Velioglu, L Hanoglu, Z Bayraktaroglu, G Toprak, EM Guler, MY Bektay, ... Neurobiology of learning and memory 180, 107410, 2021 | 47 | 2021 |
| Olanzapine attenuates brain damage after focal cerebral ischemia in vivo B Yulug, A Yildiz, O Hüdaoglu, E Kilic, E Cam, WR Schäbitz Brain Research Bulletin 71 (1-3), 296-300, 2006 | 47 | 2006 |
| Rifampicin inhibits neurodegeneration in the optic nerve transection model in vivo and after 1-methyl-4-phenylpyridinium intoxication in vitro Ü Kilic, E Kilic, P Lingor, B Yulug, M Bähr Acta neuropathologica 108, 65-68, 2004 | 43 | 2004 |
| Cinnamon polyphenol extract exerts neuroprotective activity in traumatic brain injury in male mice B Yulug, E Kilic, S Altunay, C Ersavas, C Orhan, A Dalay, M Tuzcu, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2018 | 41 | 2018 |
| Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial B Yulug, O Altay, X Li, L Hanoglu, S Cankaya, S Lam, HA Velioglu, ... Translational Neurodegeneration 12 (1), 4, 2023 | 40 | 2023 |
| Targeting different pathophysiological events after traumatic brain injury in mice: Role of melatonin and memantine T Kelestemur, B Yulug, AB Caglayan, MC Beker, U Kilic, B Caglayan, ... Neuroscience letters 612, 92-97, 2016 | 39 | 2016 |
| Risperidone attenuates brain damage after focal cerebral ischemia in vivo B Yulug, A Yildiz, O Güzel, E Kilic, WR Schäbitz, E Kilic Brain research bulletin 69 (6), 656-659, 2006 | 39 | 2006 |
